Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,932.00    40.00 (0.82%)
Bid:
4,914.00
Ask:
4,918.00
Spread: 4.00 (0.081%)
Market Cap: £17.98b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

31 Mar 2023 09:11

RNS Number : 9318U
Coca-Cola HBC AG
31 March 2023
 

FOR IMMEDIATE RELEASE

31 March 2023

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that, as a result of the satisfaction of performance conditions, the award granted on 17 March 2020 under the Company's Performance Share Award Plan ("PSP") vested on 29 March 2023 and has been transferred to the PDMR from shares held in treasury.

The following sets out the award that vested on 29 March 2023, the number of dividend equivalent shares accrued between grant and vesting and the number of shares sold following such vesting.

 PDMR

Number of shares granted under the PSP vesting

Number of dividend equivalent shares

 

Number of shares sold

VITALIY NOVIKOV

20,614

1,685

22,299

 

The Notification of Dealing Forms for the PDMR can be found below.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

VITALIY NOVIKOV

2

 

Reason for the notification

a)

 

Position/status

 

DIGITAL COMMERCE BUSINESS DEVELOPMENT DIRECTOR

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

SHARES ISSUED TO PDMR FOLLOWING VESTING OF PERFORMANCE SHARE AWARD GRANTED IN MARCH 2020 UNDER THE TERMS OF THE Performance Share Award Plan, INCLUDING DIVIDEND EQUIVALENT SHARES ACCRUED BETWEEN GRANT OF AWARD AND VESTING. SHARES ISSUED BY A TRANSFER FROM SHARES HELD IN TREASURY.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

22.082101 GBP

22,299

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

22.082101 GBP

22,299

492,408.77 GBP

e)

 

Date of the transaction

 

29 MARCH 2023

 

f)

 

Place of the transaction

 

XLON

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

 

CH0198251305

b)

 

Nature of the transaction

 

 

SALE OF SHARES ARISING FROM VESTING OF THE PERFORMANCE SHARE AWARD

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

22.082101 GBP

22,299

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

22.082101 GBP

22,299

492,408.77 GBP

e)

 

Date of the transaction

 

29 MARCH 2023

 

f)

 

Place of the transaction

 

XLON

 

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKDBDFBKKKNN
Date   Source Headline
28th Mar 20252:42 pmRNSDirector/PDMR Shareholding
28th Mar 20252:37 pmRNSDirector/PDMR Shareholding
19th Mar 20254:47 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20254:43 pmRNSDirector/PDMR Shareholding - Amendment
19th Mar 20251:40 pmRNSDirector/PDMR Shareholding
19th Mar 20251:33 pmRNSDirector/PDMR Shareholding
19th Mar 20251:30 pmRNSDirector/PDMR Shareholding
19th Mar 20251:25 pmRNSDirector/PDMR Shareholding
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding
19th Mar 20251:00 pmRNSDirector/PDMR Shareholding
18th Mar 20251:21 pmRNSDirector/PDMR Shareholding
14th Mar 20253:45 pmRNSAnnual Financial Report
13th Mar 20252:18 pmRNSDirector/PDMR Shareholding
12th Mar 20259:22 amRNSDirector/PDMR Shareholding
11th Mar 202512:17 pmRNSDirector Declaration
5th Mar 20251:19 pmRNSDirector/PDMR Shareholding
4th Mar 20256:03 pmRNSTransfer of treasury shares and voting rights
4th Mar 20254:03 pmRNSDirector/PDMR Shareholding
26th Feb 202510:07 amRNSDirector/PDMR Shareholding
18th Feb 20251:50 pmRNSDirector/PDMR Shareholding
17th Feb 20259:22 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSStrong execution drove continued profitable growth
3rd Feb 202510:09 amRNSTransfer of treasury shares and voting rights
27th Jan 20253:13 pmRNSCorrection - Total voting rights
20th Jan 20251:49 pmRNSDirector/PDMR Shareholding
15th Jan 20251:55 pmRNSNotice of Results
3rd Jan 202511:51 amRNSTotal Voting Rights
2nd Jan 20259:16 amRNSDirector/PDMR Shareholding
18th Dec 20242:19 pmRNSDirector/PDMR Shareholding
17th Dec 20244:17 pmRNSDirector/PDMR Shareholding
17th Dec 20244:09 pmRNSDirector/PDMR Shareholding
17th Dec 20243:46 pmRNSHolding(s) in Company
4th Dec 202410:50 amRNSDirector/PDMR Shareholding
4th Dec 202410:28 amRNSDirector/PDMR Shareholding
2nd Dec 202410:35 amRNSTotal Voting Rights
29th Nov 20241:40 pmRNSDirector/PDMR Shareholding
29th Nov 202410:08 amRNSDirector/PDMR Shareholding
28th Nov 20248:41 amRNSDirector/PDMR Shareholding
28th Nov 20248:23 amRNSDirector/PDMR Shareholding
19th Nov 20243:51 pmRNSDirector/PDMR Shareholding
19th Nov 202411:14 amRNSFinal Terms - 2032 Notes
13th Nov 20244:41 pmRNSDirector Declaration
13th Nov 20244:11 pmRNSPricing of Issue of Notes
13th Nov 20248:39 amRNSIssue of Debt
12th Nov 20243:56 pmRNSPublication of Suppl.Prospcts
8th Nov 202410:27 amRNSNotice of purchase
7th Nov 202411:39 amRNSDirector/PDMR Shareholding
7th Nov 202411:36 amRNSDirector/PDMR Shareholding
1st Nov 202410:12 amRNSBlock listing Interim Review
31st Oct 20247:00 amRNSStrong execution drives continued growth

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.